Abstract
Omega-3 fatty acids have been acknowledged for their number of holdings on an individual’s health. Not only in physical valuation but also in managing psychiatric disorders, omega-3 fatty acids have been found to be a powerful formula. It is proclaimed that depressive patients suffer anomaly with the levels of omega-3 polyunsaturated fatty acids in the body, coupled with insignificant EPA and DHA. Enhancement in brain functioning, neuronal functions, and paying attention in interacting with the brain cells are some of the additional tasks, being performed by the supplementation of omega-3 fatty acids. The leading and primary source via dietary supplementation involves the involvement of fish and fish products. These are hypothesized to be the best and dominant source for omega-3 fatty acids. Consumption of omega-3 fatty acid is well safe, that physician highly favors intake of these supplements, remarkably in the case of pregnant women. However, treating this serious life-threatening mental disorder leads to many adverse effects when treated with antidepressants. The dose range includes 1g/d to 10g/d, which is to be incorporated by the patient. It is also tested that the combination of EPA and DHA is found to be more efficacious for a person in treating and preventing depressive symptoms. Some studies verify the supplementation of omega-3 fatty acids in diet was coequally productive and successful with minimal side effects when analyzed with antidepressants. Despite these facts, much research is still needed and presently in process for long-term safety and studying the role of omega-3 fatty acids in human health.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable
References
Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C (2015) Tumour necrosis factor-α inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res 79:175–184. https://doi.org/10.1016/j.jpsychores.2015.04.008
Abdallah CG, Adams TG, Kelmendi B, Esterlis I, Sanacora G, Krystal JH (2016) Ketamine's mechanism of action: a path to rapid-acting antidepressants. Depress Anxiety 33:689–697. https://doi.org/10.1002/da.22501
Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC (2017) A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. In Mayo Clinic Proceedings 92:15–29. https://doi.org/10.1016/j.mayocp.2016.10.018
Almasi M (2021) Flaxseed prevents interferon-alpha induced depressive behavior in mice: the α-linolenic acid is essential. RJP 8:63–71. https://doi.org/10.22127/rjp.2020.246950.1622
Anita NZ, Forkan N, Kamal R et al (2021) Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes. Psychoneuroendocrinology 126:105149. https://doi.org/10.1016/j.psyneuen.2021.105149
Artukoglu BB, Bloch MH (2018) Can omega-3 fatty acids improve executive functioning? Will this reduce ADHD and depression? 59:615–617. https://doi.org/10.1111/jcpp.12932
Asif M (2011) Health effects of omega-3, 6, 9 fatty acids: Perilla frutescens is a good example of plant oils. Orient Pharm Exp Med 11:51–59. https://doi.org/10.1007/s13596-011-0002-x
Bae JH, Kim G (2018) Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression. Nutr Res 50:1–9. https://doi.org/10.1016/j.nutres.2017.10.013
Barbora K, Magdaléna V, IvetaW SO, Iveta G (2020) Lipid profile, lipoprotein subfractions, and fluidity of membranes in children and adolescents with depressive disorder: effect of omega-3 fatty acids in a double-blind randomized controlled study. Biomolecules 1427. https://doi.org/10.3390/biom10101427
Bazinet RP, Metherel AH, Chen CT, Shaikh SR, Nadjar A, Joffre C, Layé S (2020) Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression. Brain Behav Immun 85:21–28. https://doi.org/10.1016/j.bbi.2019.07.001
Bento AF, Claudino RF, Dutra RC (2011) Omega-3 fatty acid-derived mediators 17 (R)-hydroxydocosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol:1957–1969. https://doi.org/10.4049/jimmunol.1101305
Berger ME, Smesny S, Kim SW (2017) Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study. Transl Psychiatry 7:e1220–e1220. https://doi.org/10.1038/tp.2017.190
Berk M, Agustini B, Woods RL, Nelson MR, Shah RC, Reid CM (2021) Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial. Mol Psychiatry:1–10
Bordoni B, Marelli F, Morabito B, Sacconi B (2018) Depression and anxiety in patients with chronic heart failure. Futur Cardiol 14:115–119. https://doi.org/10.2217/fca-2017-0073
Bowman L, Mafham M, Stevens W, Haynes R (2018) ASCEND: a study of cardiovascular events in diabetes: characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes. Am Heart J 198:135–144. https://doi.org/10.1016/j.ahj.2017.12.006
Bozzatello P, Rocca P, Mantelli E, Bellino S (2019) Polyunsaturated fatty acids: what is their role in treatment of psychiatric disorders? Int J Mol Sci 20:5257. https://doi.org/10.3390/ijms20215257
Calear AL, Christensen H (2010) Systematic review of school-based prevention and early intervention programs for depression. J Adolesc 33:429–438. https://doi.org/10.1016/j.adolescence.2009.07.004
Cao B, Chen Y, Brietzke E (2018) Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis. J Affect Disord 238:101–110. https://doi.org/10.1016/j.jad.2018.05.008
Chauhan B, Kumar G, Kalam N, Ansari SH (2013) Current concepts and prospects of herbal nutraceutical: a review. J Adv Pharm Technol 4:4–8. https://doi.org/10.4103/2231-4040.107494
Chi S, Lee MS (2021) Personalized medicine using neuroimmunological biomarkers in depressive disorders. J Pers Med 11:114. https://doi.org/10.3390/jpm11020114
Dantzer R (2012) Depression and inflammation: an intricate relationship. Biol Psychiatry 71:4–5. https://doi.org/10.1016/j.biopsych.2011.10.025
Delpino FM, Figueiredo LM, da Silva BGC, da Silva TG, Mintem GC, Bielemann RM, Gigante DP (2021) Omega-3 supplementation and diabetes: a systematic review and meta-analysis. Crit Rev Food Sci Nutr:1–14. https://doi.org/10.1080/10408398.2021.1875977
dos Santos VJ, Farias DR et al (2017) Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial. BMC Pregnancy and Childbirth 17:1–13. https://doi.org/10.1186/s12884-017-1365-x
Dowlati Y, HerrmannN SW, Liu H et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457. https://doi.org/10.1016/j.biopsych.2009.09.033
Ertmann RK, Nicolaisdottir DR, Kragstrup J, Siersma V, Lutterodt MC (2019) Physical discomfort in early pregnancy and postpartum depressive symptoms. Nord J Psychiatry 73:200–206. https://doi.org/10.1080/08039488.2019.1579861
Farioli-Vecchioli S, Sacchetti S, di Robilant NV, Cutuli D (2018) The role of physical exercise and omega-3 fatty acids in depressive illness in the elderly. Curr Neuropharmacol 16:308–326. https://doi.org/10.2174/1570159X15666170912113852
Fristad MA, Roley-Roberts ME, Black SR, Arnold LE (2021) Moody kids years later: long-term outcomes of youth from the omega-3 and therapy (OATS) studies. J. Affect Disord 281:24–32. https://doi.org/10.1016/j.jad.2020.11.115
Gabbay V, Freed RD, Alonso CM, Senger S, Stadterman J, Davison BA, Klein RG (2018) A double-blind placebo-controlled trial of omega-3 fatty acids as a monotherapy for adolescent depression. J Clin Psychiatry 79. https://doi.org/10.4088/JCP.17m11596
Gananca L, Galfalvy HC, Cisneros-Trujillo S, Basseda Z, Cooper TB et al (2021) Relationships between inflammatory markers and suicide risk status in major depression. J Psychiatr Res 134:192–199. https://doi.org/10.1016/j.jpsychires.2020.12.029
Ghaedrahmati M, KazemiA KG, BahramiM EA (2018) Examining the relationship between mothers' prenatal mental health and demographic factors with postpartum depression. JEHP 7. https://doi.org/10.4103/jehp.jehp_6_18
Godos J, Castellano S, Galvano F, Grosso G (2019) Linking omega-3 fatty acids and depression. In Omega fatty acids in brain and neurological health:199–212. https://doi.org/10.1016/B978-0-12-815238-6.00013-4
Goh KK, Chen CYA, Chen CH, Lu ML (2021) Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: a meta-analysis of randomized controlled trials. Int J Women's Health. https://doi.org/10.1177/0269881120981392
Gould JF, Roberts RM, Makrides M (2021) The influence of omega-3 long-chain polyunsaturated fatty acid, docosahexaenoic acid, on child behavioral functioning: a review of randomized controlled trials of DHA supplementation in pregnancy, the neonatal period and infancy. Nutrients 13:415. https://doi.org/10.3390/nu13020415
Gumus CE, Gharibzahedi S (2021) Yogurts supplemented with lipid emulsions rich in omega-3 fatty acids: new insights into the fortification, microencapsulation, quality properties, and health-promoting effects. Trends Food Sci Technol 110:267–279. https://doi.org/10.1016/j.tifs.2021.02.016
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK et al (2019) International Society for Nutritional Psychiatry Research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychother Psychosom 88:263–273. https://doi.org/10.1159/000502652
Häberling I, Berger G, Schmeck K, Held U, Walitza S (2019) Omega-3 fatty acids as a treatment for pediatric depression. A phase III, 36 weeks, multi-center, double-blind, placebo-controlled randomized superiority study. Front Psychol 10:863. https://doi.org/10.3389/fpsyt.2019.00863
Hamazaki K (2019) Role of omega-3 polyunsaturated fatty acids in mental health—studies from Japan. J Oleo Sci:19008. https://doi.org/10.5650/jos.ess19008
Hawkey E, Nigg JT (2014) Omega− 3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 34:496–505. https://doi.org/10.1016/j.cpr.2014.05.005
Howell EA, Bodnar-Deren S, Balbierz A, Loudon H, Mora PA, Zlotnick C, Leventhal H (2014) An intervention to reduce postpartum depressive symptoms: a randomized controlled trial. Archives of Women's Mental Health 17:57–63
Hsu MC, Tung CY, Chen HE (2018) Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: putative mechanism and recommendation. J Affect Disord 238:47–61. https://doi.org/10.1016/j.jad.2018.05.018
Huang CB, Ebersole JL (2010) A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives. Mol Oral Microbiol 25:75–80. https://doi.org/10.1111/j.2041-1014.2009.00553.x
Huybrechts KF, PalmstenK M, Kowal H et al (2013) National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp 35:265–271. https://doi.org/10.1016/j.genhosppsych.2012.12.010
Jantaratnotai N, Mosikanon K, LeeY (2017) McIntyre, R. S. The interface of depression and obesity. Obes Res Clin Pract 11:1–10. https://doi.org/10.1016/j.orcp.2016.07.003
Jia X, Kohli P, Virani SS (2019) Omega-3 fatty acid and cardiovascular outcomes: insights from recent clinical trials. Curr Atheroscler Rep 21:1
Jiang W, Whellan DJ, Adams KF, Babyak MA, Boyle SH, Wilson (2018) Long-chain omega-3 fatty acid supplements in depressed heart failure patients: results of the OCEAN trial. JACC: Heart Failure Asia Pac Psychiatry 6:833–843. https://doi.org/10.1016/j.jchf.2018.03.011
Judge MP, Beck CT, Durham H, MME MK et al (2014) Pilot trial evaluating maternal docosahexaenoic acid consumption during pregnancy: decreased postpartum depressive symptomatology. Int J Nurs Sci 1:339–345. https://doi.org/10.1016/j.ijnss.2014.10.005
Kettunen P, Hintikka J (2017) Psychosocial risk factors and treatment of new onset and recurrent depression during the post-partum period. Nord J Psychiatry 71:355–361. https://doi.org/10.1080/08039488.2017.1300324
Kwon Y (2020) Immuno-resolving ability of resolvins, protectins, and maresins derived from omega-3 fatty acids in metabolic syndrome. Mol Nutr Food Res 64:1900824. https://doi.org/10.1002/mnfr.201900824
Laino CH, Fonseca C, Sterin-Speziale N, Slobodianik N, Reinés A (2010) Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine. Eur J Pharmacol 648:117–126. https://doi.org/10.1016/j.ejphar.2010.08.047
Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH (2021) Dose-and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukot Essent Fat Acids 164:102219. https://doi.org/10.1016/j.plefa.2020.102219
Latendresse G, Ruiz RJ, Wong B (2013) Psychological distress and SSRI use predict variation in inflammatory cytokines during pregnancy. Open Obstet Gynecol 3:184–191. https://doi.org/10.4236/ojog.2013.31A034
Lee HJ, Haq M, Saravana PS, ChoYN CBS (2017) Omega-3 fatty acids concentrate production by enzyme-catalyzedethanolysis of supercritical CO 2 extracted oyster oil. Biotechnol:22518–22528. https://doi.org/10.1007/s12257-017-0293-y
Lin PY, Mischoulon D, Freeman MP, Matsuoka Y et al (2012) Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry 17:1161–1163
Lin PY, Chang CH, ChongMFF CH et al (2017) Polyunsaturated fatty acids in perinatal depression: a systematic review and meta-analysis. Biol Psychiatry 82:560–569. https://doi.org/10.1016/j.biopsych.2017.02.1182
Liu Y, Ho RCM, Mak A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 139:230–239. https://doi.org/10.1016/j.jad.2011.08.003
Lyall AE, NägeleFL PO, Gallego JA, Malhotra AK, McNamara RK (2021) A 16-week randomized placebo-controlled trial investigating the effects of omega-3 polyunsaturated fatty acid treatment on white matter microstructure in recent-onset psychosis patients concurrently treated with risperidone. Psychiatry Res Neuroimaging 307:111219. https://doi.org/10.1016/j.pscychresns.2020.111219
Ma L, Zhang Y, Cui Z (2019) Mindfulness-based interventions for prevention of depressive symptoms in university students: a meta-analytic review. Mindfulness 10:2209–2224
Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D (2012) The vitamin D and omega-3 trial (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary Clinical Trials 33:159–171. https://doi.org/10.1016/j.cct.2011.09.009
Massaro M, Scoditti E, Carluccio MA, Campana MC, De Caterina R (2010) Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell Mol Biol 56:59–82
Matrisciano F, Pinna G (2020) PPAR and functional foods: rationale for natural neurosteroid-based interventions for postpartum depression. Neurobiol 12:100222. https://doi.org/10.1016/j.ynstr.2020.100222
Matsuoka YJ, Sawada N, Mimura M, Shikimoto RS et al (2017) Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study. Transl Psychiatry 7:e1242. https://doi.org/10.1038/tp.2017.206
McEvoy K, Payne JL, Osborne LM (2018) Neuroactive steroids and perinatal depression: a review of recent literature. Curr Psychiatry Rep 20:1–9. https://doi.org/10.1007/s11920-018-0937-4
Milgrom J, Schembri C, Ericksen J, Ross J, Gemmill AW (2011) Towards parenthood: an antenatal intervention to reduce depression, anxiety and parenting difficulties. J Affect Disord 130:385–394. https://doi.org/10.1016/j.jad.2010.10.045
Miller ES, Grobman WA, Culhane J, Adam E, Buss C, Entringer S, Miller G, Wadhwa PD, Keenan-Devlin L, Borders A (2018) Antenatal depression, psychotropic medication use, and inflammation among pregnant women. Archives of Women's Mental Health 21:785–790
NabbeP LRJY, Guillou-Landreat M et al (2017) Which DSM validated tools for diagnosing depression are usable in primary care research? A systematic literature review. European Psychiatry 39:99–105. https://doi.org/10.1016/j.eurpsy.2016.08.004
Nagayasu Y, Fujita D, Daimon A, Nunode M, Sawada M, Sano T, Ohmichi M (2021) Possible prevention of post-partum depression by intake of omega-3 polyunsaturated fatty acids and its relationship with interleukin 6. J Obstet Gynaecol 47:1371–1379. https://doi.org/10.1111/jog.14592
Nahas R, Sheikh O (2011) Complementary and alternative medicine for the treatment of major depressive disorder. Can Fam Physician 57:659–663
Namara RK (2016) Role of omega-3 fatty acids in the etiology, treatment, and prevention of depression: current status and future directions. J Nutr Intermed 5:96–106. https://doi.org/10.1016/j.jnim.2016.04.004
Nasri H, Baradaran A, Shirzad H, Rafieian-Kopaei M (2014) New concepts in nutraceuticals as alternative for pharmaceuticals. Int J Prev Med 5:1487
Nishi D, Su KP, Usuda K, Chang JPC, Chiang YJJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Hashimoto K, Hamazaki T, Matsuoka YJ (2019) Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: an open-label pilot study. Nutr Neurosci 22:63–71. https://doi.org/10.1080/1028415X.2017.1354540
Nishi D, Su KP, Usuda K, Chang JPC, Hamazaki K, Ishima T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Matsuoka YJ (2020) Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women. Brain Behav Immun 85:29–34. https://doi.org/10.1016/j.bbi.2019.02.014
Nivetha K, Rao AS, Nair A (2021) Microbial production of omega-3 fatty acids: an overview. J Appl Microbiol. https://doi.org/10.1111/jam.15034
NouriSaeidlou S, Kian A, Ayremlou P (2021) Association between dietary patterns and major depression in adult females: a case-control study. J Res Health Sci 21:7. https://doi.org/10.34172/jrhs.20201.37
Opiyo RO, Nyasulu PS, Koigi RK, Obondo A, Ogoyi D, Kogi-Makau W (2018) Effect of fish oil omega-3 fatty acids on reduction of depressive symptoms among HIV-seropositive pregnant women: a randomized, double-blind controlled trial. Arch Gen Psychiatry 17:1–16. https://doi.org/10.1186/s12991-018-0220-4
Park SJ, Lee DK, Kim B, Na KS (2020) The association between omega-3 fatty acid intake and human brain connectivity in middle-aged depressed women. Nutrients 12:2191. https://doi.org/10.3390/nu12082191
Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2010) Clinical implications of the cytokine hypothesis of depression. Psychother Psychosom 79:323–325. https://doi.org/10.1159/000319530
Patrick RP, Ames BN (2015) Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 29:2207–2222. https://doi.org/10.1096/fj.14-268342
Prakash D, Gupta C, Sharma G (2012) Importance of phytochemicals in nutraceuticals. J Chin Med Res 1:70–78
Reimers A, Ljung H (2019) The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. Therapeutic advances in psychopharmacology 9:204512531985890. https://doi.org/10.1177/2045125319858901
Sánchez-Villegas A, Álvarez-Pérez J, Toledo E, Salas-Salvadó J et al (2018) Seafood consumption, omega-3 fatty acids intake, and life-time prevalence of depression in the PREDIMED-plus trial. Nutrients. 10:2000–2009. https://doi.org/10.1080/0167482X.2018.1508282
Saveanu RV, Nemeroff CB (2012) Etiology of depression: genetic and environmental factors. Psychiatr Clin 35:51–71. https://doi.org/10.1016/j.psc.2011.12.001
Singh JE (2020) Dietary Sources of Omega-3 Fatty acids versus omega-3 fatty acid supplementation effects on cognition and inflammation. Cur Nutr Rep:1–14
Sousa TMD, Santos LCD (2020) Dietary fatty acids, omega-6/omega-3 ratio and cholesterol intake associated with depressive symptoms in low-risk pregnancy. Nutr Neurosci:1–6. https://doi.org/10.1080/1028415X.2020.1792618
Thesing CS, LamersF BM et al (2019) Response to “International Society for Nutritional Psychiatry Research Practice Guidelines for omega-3 fatty acids in the treatment of major depressive disorder” by Guu et al. Psychother Psychosom 89:48–48. https://doi.org/10.1159/000504100
Thesing CS, Bot M, Milaneschi Y, Giltay EJ, Penninx BW (2020) Bidirectional longitudinal associations of omega-3 polyunsaturated fatty acid plasma levels with depressive disorders. J Psychiatr Res 124:1–8. https://doi.org/10.1016/j.jpsychires.2020.02.011
Trebatická J, Dukát A, Ďuračková Z, Muchová J (2017a) Cardiovascular diseases, depression disorders and potential effects of omega-3 fatty acids. Physiol Res 66:363–382. https://doi.org/10.33549/physiolres.933430
Trebatická J, Hradečná Z, Böhmer F, Vaváková M et al (2017b) Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study. Child Adolesc Psychiatry Ment Health 11:1–10
Trebatická J, Hradečná Z, Surovcová A, Katrenčíková B, Gushina I, Waczulíková I, Sušienková K, Garaiova I, Šuba J, Ďuračková Z (2020) Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6/omega-3 ratio in children. A randomized, double-blind and controlled trial. Psychiatry Res 287:112911. https://doi.org/10.1016/j.psychres.2020.112911
Viguera A (2019) Severe postpartum unipolar major depression: choosing treatment. UpToDate 375:2177–2186. https://doi.org/10.1056/NEJMcp1607649
Yang Y, Kim Y, Je Y (2018) Fish consumption and risk of depression: epidemiological evidence from prospective studies. Asia Pac Psychiatry 10:e12335. https://doi.org/10.1111/appy.12335
Yeum TS, Maggiolo NS, Gupta CT, Davis BJ, Nierenberg AA, Sylvia LG (2019) Adjunctive nutrition therapy for depression. Psychiatr Ann 49:21–25. https://doi.org/10.3928/00485713-20181205-02
Yohn CN, Gergues MM, Samuels BA (2017) The role of 5-HT receptors in depression. Molecular brain 10:1–12
Yonezawa K, Kusumoto Y, Kanchi N, Kinoshita H, Kanegae S, Yamaguchi N (2020) Ozawa, H. Recent trends in mental illness and omega-3 fatty acids. J Neural Transm 127:1491–1499
Yu H, Chen ZY (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta PharmacologicaSinica 32:3–11. https://doi.org/10.1038/aps.2010.184
Zhang R, Sun J, Li Y (2020) Associations of n-3, n-6 fatty acids intakes and n-6: n-3 ratio with the risk of depressive symptoms: NHANES 2009–2016. Nutrients 12:240. https://doi.org/10.3390/nu12010240
Zhao WN, Hylton NK, Wang J, Chindavong PS, Alural B, Kurtser I, Subramanian A, Mazitschek R, Perlis RH, Haggarty SJ (2019) Activation of WNT and CREB signaling pathways in human neuronal cells in response to the omega-3 fatty acid docosahexaenoic acid (DHA). Mol Cell Neurosci 99:103386. https://doi.org/10.1016/j.mcn.2019.06.006
Author information
Authors and Affiliations
Contributions
Conceptualization, PS and TB; writing—original draft preparation, PS and TB; figure making: SS, AS, SSN, and NS; writing—review and editing, PS, TB, and SB; proofreading, AAH and LA.
Corresponding author
Ethics declarations
Ethics approval
Not applicable
Consent to participate
Not applicable
Consent for publication
All the authors have approved the manuscript for publication.
Competing interests
The authors declare no competing interests.
Additional information
Responsible Editor: Philippe Garrigues
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sikka, P., Behl, T., Sharma, S. et al. Exploring the therapeutic potential of omega-3 fatty acids in depression. Environ Sci Pollut Res 28, 43021–43034 (2021). https://doi.org/10.1007/s11356-021-14884-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-021-14884-5